Breakthrough pain variability has no impact on response to sublingual fentanyl tablets or placebo
Variability in baseline breakthrough pain (BTP) has no impact on the analgesic response to sublingual fentanyl tablets or placebo.
All articles by Jenny Ko, PharmD
Milnacipran Improves Pain, Other Symptoms of Fibromyalgia
Milnacipran treatment resulted in improvements in pain and global status regardless of baseline pain severity or fibromyalgia severity.
Duloxetine, pregabalin, and duloxetine + gabapentin safe for diabetic peripheral neuropathic pain
Duloxetine, pregabalin, and duloxetine + gabapentin were found to be safe and tolerable for the treatment of diabetic peripheral neuropathic pain.
Efficacy and safety of IV tanezumab in osteoarthritis hip and knee pain
Tanezumab, a monoclonal antibody that inhibits nerve growth factor, is efficacious in treating osteoarthritis pain and may provide greater symptomatic improvement compared with placebo and naproxen.
-
Loading...
-
Loading...
